54788-19-1

Basic information

• Product Name: 2-FLUORO-4-METHOXYBENZYL BROMIDE
• Synonyms: 2-FLUORO-4-METHOXYBENZYL BROMIDE;2-Fluoro-4-methoxybenzyl bromide 97%;4-(Bromomethyl)-3-fluoroanisole, 1-(Bromomethyl)-2-fluoro-4-methoxybenzene;1-(BroMoMethyl)-2-fluoro-4-Methoxybenzene
• CAS NO: 54788-19-1
• Molecular Formula: C₈H₈BrFO
• Molecular Weight: 219.06
• Mol File: 54788-19-1.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 228.561°C at 760 mmHg
• Flash Point: 110.774°C
• Appearance: /
• Density: 1.489g/cm³
• Vapor Pressure: 0.11mmHg at 25°C
• Refractive Index: 1.532
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2-FLUORO-4-METHOXYBENZYL BROMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-FLUORO-4-METHOXYBENZYL BROMIDE(54788-19-1)
• EPA Substance Registry System: 2-FLUORO-4-METHOXYBENZYL BROMIDE(54788-19-1)

Safety Data

• RIDADR: 3265
• HazardClass: 8
• PackingGroup: Ⅲ
• Hazardous Substances Data: 54788-19-1(Hazardous Substances Data)

Usage

InChI:InChI=1/C8H8BrFO/c1-11-7-3-2-6(5-9)8(10)4-7/h2-4H,5H2,1H3

Upstream product

• 405-09-4 (2-fluoro-4-methoxyphenyl)methanol 
• 405-06-1 2-fluoro-4-methoxy-1-methylbenzene 
• 372-20-3 3-fluorophenol 
• 348-27-6 2-fluoro-4-hydroxybenzaldehyde 
• 331-64-6 2-fluoro-4-methoxy-benzaldehyde 
• 114635-97-1 3-<(dimethyl-tert-butylsilyl)oxy>fluorobenzene 

Downstream Products

• 749934-29-0 2-(2-fluoro-4-methoxyphenyl)acetonitrile 
• 78709-81-6 2-fluoro-L-tyrosine 

Relevant articles and documents

Methylene versus carbonyl bridge in the structure of new tubulin polymerization inhibitors with tricyclic A-rings

The phenothiazine group has been identified as a suitable A ring in the structure of tubulin polymerization inhibitors. In our search to identify more potent inhibitors, a study of different isosteric tricyclic groups as new potential A rings was first re

1-SUBSTITUTED-3- BETA-D-GLUCOPYRANOSYLATED NITROGENOUS HETERO- CYCLIC COMPOUNDS AND MEDICINES CONTAINING THE SAME

A compound having an SGLT1 and/or SGLT2 inhibitory activity which is usable as an agent for the prevention or treatment of diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity, etc. It is a 1-substituted-3-(β-D

Asymmetric synthesis of fluorinated L-tyrosine and meta-L-tyrosines

A convenient asymmetric synthesis of (2S)-2-amino-3-(2-fluoro-5-hydroxyphenyl) propanoic acid, (2S)-2-amino-3-(4-fluoro-3-hydroxyphenyl) propanoic acid and (2S)-2-amino-3-(2-fluoro-4-hydroxyphenyl) propanoic acid is described.Key steps include the synthes